Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allergic Rhino-Conjunctivitis”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Testing effectiveness (Phase 2)Study completedNCT00574379
What this trial is testing

Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR

Who this might be right for
Seasonal Allergic RhinitisHay FeverAllergic Conjunctivitis+1 more
Faes Farma, S.A. 805
Not applicableStudy completedNCT04322838
What this trial is testing

Tromsø Birch Rust Allergy Study. Allergy to Birch Rust, a Possible Explanation to Seasonal Airway Allergy During Autumn?

Who this might be right for
Hypersensitivity, ImmediateAllergy
University Hospital of North Norway 48
Testing effectiveness (Phase 2)Study completedNCT01425788
What this trial is testing

Comparison of Different Up-dosing Schedules With Osiris Phleum Pratense

Who this might be right for
Rhino-conjunctivitis
ALK-Abelló A/S 236
Testing effectiveness (Phase 2)Study completedNCT02271009
What this trial is testing

Compare Dose Regimens of AllerT, in Adults With Allergic Rhino-Conjunctivitis to Birch Pollen Studied in EEC

Who this might be right for
Allergic Rhino-Conjunctivitis
Anergis 213
Not applicableStudy completedNCT05661812
What this trial is testing

Norwegian Birch Rust Allergy Study

Who this might be right for
Hypersensitivity, Immediate
University Hospital of North Norway 287
Testing effectiveness (Phase 2)Study completedNCT00652223
What this trial is testing

Effect of an Allergen Vaccine in Patients With Allergic Rhino-Conjunctivitis and Asthma Due to House Dust Mite Allergy

Who this might be right for
Perennial Allergic RhinoconjunctivitisAllergic Asthma
Cytos Biotechnology AG 21
Early research (Phase 1)Study completedNCT07042828
What this trial is testing

To Compare and Evaluate the Oral Bioavailability of Bilastine 20 mg Orally Dispersible Tablet With That of Bilaxten (Bilastine) 20 mg Orally Dispersible Tablet in Healthy, Adult, Human Subjects Under Fasting Conditions

Who this might be right for
Allergic Rhino-ConjunctivitisUrticaria
Humanis Saglık Anonim Sirketi 42
Not applicableStudy completedNCT01486498
What this trial is testing

Quality of Life and Health Economic Measurements in Allergic Patients Treated With Immunotherapy

Who this might be right for
HypersensitivityAsthmaRhino-Conjunctivitis+2 more
Aalborg University 571
Post-approval studies (Phase 4)UnknownNCT02277483
What this trial is testing

Efficacy and Safety of LAIS® Mites Sublingual Tablets

Who this might be right for
Allergic Conditions
Ajou University School of Medicine 45
Testing effectiveness (Phase 2)Study completedNCT02686827
What this trial is testing

DBPC-Dose-finding-trial of Vitamin D3 for SCIT in Birch Pollen Allergic Patients.

Who this might be right for
Hypersensitivity
Laurian Jongejan 44
Early research (Phase 1)Study completedNCT04912076
What this trial is testing

S.C. Immunotherapy With BM41 in Patients With Allergic Rhino-conjunctivitis Caused by Birch Pollen

Who this might be right for
Birch Pollen AllergyAllergic Rhinoconjunctivitis
Odense University Hospital 47